GENOTECH CORP.
Supplies synthetic genes (GenOligo) and DNA sequencing analysis services for biotech research.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1997 and listed on KONEX in 2016, Genotech is a medical device company specializing in gene synthesis and analysis. It supplies synthetic genes (GenOligo, Kit) used as essential materials in biotech research, along with gene analysis services that sequence customer-submitted samples. Revenue is split 58.5% from synthetic gene products, 41.3% from gene analysis services, and 0.2% from other sources such as leasing and merchandise sales.
Products & technology
- Synthetic genes (GenOligo, Kit)Essential material for gene manipulation, PCR, cloning, and sequencing in biotech research
- Gene analysis serviceSequencing of customer-submitted samples and delivery of analysis results
Regulatory approvals
data.go.kr4 Korean MFDS device approvals · 2005–2014
- MFDSOther reagents, classⅡ, for molecular diagnostics2014-05-30Product approval · Class 2체외 제인 14-1103 호
- MFDSIVD reagents for histocompatibility antigen, antibody not for transfusion or transplantation but for specific disease diagnosis, molecular diagnostics2014-05-30Product approval · Class 2체외 제인 14-1104 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2013-01-02Product approval · Class 3체외 제허 13-76 호
- MFDSOrthopedic materialsRevoked2005-09-20Product approval · Class 2수허 05-880 호
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed precision-diagnostics company manufacturing genomic diagnostic reagents and developing related software.
Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition